GlassScriptPhysician profile
Karl M Letko
NPI 1689977019
$4,127.74
in general payments reported to CMS, 2019-2025
18 companies · $1,125 in 2025
The $1,125 reported for 2025 was more than what 85% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $627 · 2022: $643 · 2023: $742 · 2024: $992 · 2025: $1,125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,858.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,858.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $940.02 | 2021-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Abbvie INC. | $658.15 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $465.92 | 2021-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $407.75 | 2021-2025 | Caplyta |
| Axsome Therapeutics, INC. | $291.63 | 2022-2025 | Auvelity |
| Janssen Pharmaceuticals, INC | $286.97 | 2021-2025 | Invega Sustenna |
| Alkermes, INC. | $278.16 | 2021-2025 | Aristada, Lybalvi, Vivitrol |
| Vanda Pharmaceuticals INC. | $241.51 | 2024-2025 | Fanapt |
| Takeda Pharmaceuticals U.S.A., INC. | $175.47 | 2021-2025 | Trintellix |
| Sunovion Pharmaceuticals INC. | $111.88 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $70.21 | 2024-2025 | Cobenfy |
| Neurocrine Biosciences, INC. | $63.37 | 2025 | |
| Indivior INC. | $62.47 | 2022-2023 | Perseris |
| Lundbeck LLC | $16.87 | 2023 | Rexulti |
| Eisai INC. | $15.63 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $15.13 | 2021 | |
| Jazz Pharmaceuticals INC. | $14.26 | 2021 | |
| Almatica Pharma LLC | $12.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karl Letko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.